The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial | Zendy

Erika Opingari | Zendy; Subodh Verma | Zendy; Kim A. Connelly | Zendy; C. David Mazer | Zendy; Hwee Teoh | Zendy; Adrian Quan | Zendy; Fei Zuo | Zendy; Yi Pan | Zendy; Deepak L. Bhatt | Zendy; Bernard Zinman | Zendy; Lawrence A. Leiter | Zendy; Andrew T. Yan | Zendy; David Z.I. Cherney | Zendy; Richard E. Gilbert | Zendy

Open Access

The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial

Author(s) -

Erika Opingari,

Subodh Verma,

Kim A. Connelly,

C. David Mazer,

Hwee Teoh,

Adrian Quan,

Fei Zuo,

Yi Pan,

Deepak L. Bhatt,

Bernard Zinman,

Lawrence A. Leiter,

Andrew T. Yan,

David Z.I. Cherney,

Richard E. Gilbert

Publication year - 2020

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfz294

Subject(s) - empagliflozin , medicine , type 2 diabetes , benzhydryl compounds , renal function , cardiac function curve , diabetes mellitus , cardiology , endocrinology , heart failure , chemistry , organic chemistry , bisphenol a , epoxy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog